- 专利标题： NITROGEN-CONTAINING HETEROCYCLIC COMPOUND
-
申请号： US17872680申请日： 2022-07-25
-
公开(公告)号： US20220411413A1公开(公告)日： 2022-12-29
- 发明人: Masami YAMADA , Shinkichi SUZUKI , Takahiro SUGIMOTO , Minoru NAKAMURA , Hiroki SAKAMOTO , Makoto KAMATA
- 申请人： Takeda Pharmaceutical Company Limited
- 申请人地址： JP Osaka-shi
- 专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人地址： JP Osaka-shi
- 优先权： JP2014-089585 20140423
- 主分类号： C07D405/14
- IPC分类号： C07D405/14 ; C07D209/46 ; C07D401/10 ; C07D401/14 ; C07D403/04 ; C07D403/10 ; C07D401/06 ; C07D405/04 ; A61K31/4035 ; A61K31/4155 ; A61K31/4439 ; A61K31/13 ; A61K31/325 ; A61K31/445 ; A61K31/55 ; A61K31/045 ; A61K31/4406
摘要：
The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies, and the like.
The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the specification, or a salt thereof.
The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the specification, or a salt thereof.
信息查询
